Inside the race to put computers in the human brain
Reported by Fortune1 source ↓
What will we surrender when companies become intermediaries between our minds and machines?
Key points
- Neuralink’s N1 implant is being tested in about 26 people with severe disabilities
- Synchron says it has implanted its Stentrode device in 15 people
- No brain implants are currently available on the U.S. market
- Neuralink has raised $1.3 billion, more than twice as much as the next-best-funded implant company
Details
Neuralink’s N1 implant records brain signals through electrodes and transmits the data to a phone or tablet. Fortune reports that the roughly 26 people using it in testing have severe disabilities; users can perform tasks such as texting and playing games without using their hands. The company was valued at about $9.7 billion in 2025.
Synchron is also pursuing FDA approval. Its Stentrode is less invasive than Neuralink’s device and does not require a craniotomy, Fortune reports. Synchron CEO Thomas Oxley told Fortune that the company has implanted the device in 15 people, up from 10 the previous year; Neuralink’s trial grew from seven people to 26 over the same period.
Other U.S. companies named in the report include Paradromics, which is focused on restoring speech, and Precision Neuroscience, which is developing an interface for people with paralysis. Neuvotion CEO Chad Bouton said he thinks an FDA clearance for a brain-computer interface could come in the next three or four years. The article does not report an approved date for any brain implant to reach the U.S. market.
Written from coverage as of
Images
- Fortune